Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
3.46
↓ 44% below average
Average (9y)
6.22
Historical baseline
Range
High:11.82
Low:3.46
CAGR
-12.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 3.46 | -36.2% |
| 2023 | 5.42 | +33.2% |
| 2022 | 4.07 | -3.6% |
| 2021 | 4.22 | -13.7% |
| 2020 | 4.89 | -10.1% |
| 2019 | 5.44 | +3.5% |
| 2018 | 5.26 | -37.3% |
| 2017 | 8.38 | -9.4% |
| 2016 | 9.25 | -21.7% |
| 2015 | 11.82 | - |